Cargando…

Human Milk and Plasma Pharmacokinetics of Single-Dose Rimegepant 75 mg in Healthy Lactating Women

OBJECTIVE: Investigate whether rimegepant—an oral small molecule calcitonin gene-related peptide receptor antagonist for the treatment of migraine—is excreted in human milk after a single 75 mg dose and characterize its concentration–time profile in the plasma and milk of healthy lactating women to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baker, Teresa E., Croop, Robert, Kamen, Lisa, Price, Patty, Stock, David A., Ivans, Andrea, Bhardwaj, Rajinder, Anderson, Matt S., Madonia, Jennifer, Stringfellow, Joseph, Bertz, Richard, Coric, Vladimir, Hale, Thomas W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2022
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972016/ https://www.ncbi.nlm.nih.gov/pubmed/35049333 http://dx.doi.org/10.1089/bfm.2021.0250

Ejemplares similares

P‐Glycoprotein and Breast Cancer Resistance Protein Transporter Inhibition by Cyclosporine and Quinidine on the Pharmacokinetics of Oral Rimegepant in Healthy Subjects
por: Bhardwaj, Rajinder, et al.
Publicado: (2022)

Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine
por: Berman, Gary, et al.
Publicado: (2020)

Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving Rimegepant
por: Johnston, Karissa M., et al.
Publicado: (2021)

Rimegepant, Ubrogepant, and Lasmiditan in the Acute Treatment of Migraine Examining the Benefit-Risk Profile Using Number Needed to Treat/Harm
por: Johnston, Karissa M, et al.
Publicado: (2022)

Matching‐adjusted indirect comparisons of oral rimegepant versus placebo, erenumab, and galcanezumab examining monthly migraine days and health‐related quality of life in the treatment of migraine
por: Popoff, Evan, et al.
Publicado: (2021)

Health State Utility Mapping of Rimegepant for the Preventive Treatment of Migraine: Double-Blind Treatment Phase and Open Label Extension (BHV3000-305)
por: Powell, Lauren C., et al.
Publicado: (2022)

Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double‐blind, randomized, placebo‐controlled, dose‐ranging trial
por: Croop, Robert, et al.
Publicado: (2022)

Antagonism of CGRP Signaling by Rimegepant at Two Receptors
por: Pan, Kylie S., et al.
Publicado: (2020)

ICER’s assessment of lasmiditan, rimegepant, and ubrogepant for acute migraine
por: Franklin, Meg, et al.
Publicado: (2020)

Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine
por: Blair, Hannah A.
Publicado: (2023)

Correction to: Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine
por: Blair, Hannah A.
Publicado: (2023)

Monthly migraine days, tablet utilization, and quality of life associated with Rimegepant – post hoc results from an open label safety study (BHV3000–201)
por: Johnston, Karissa, et al.
Publicado: (2022)

Use of Rimegepant in the Management of Cervicogenic Headache Secondary to Trauma: A Case Series
por: Zaw, Shin T, et al.
Publicado: (2023)

Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine: Evidence From Randomized Controlled Trials
por: Gao, Bixi, et al.
Publicado: (2020)

Clinical efficacy and safety of rimegepant in the treatment of migraine: a meta-analysis of randomized controlled trials
por: Wang, Qinghui, et al.
Publicado: (2023)

Relative efficacy of lasmiditan versus rimegepant and ubrogepant as acute treatments for migraine: network meta-analysis findings
por: Polavieja, Pepa, et al.
Publicado: (2022)

Is the right way to go in between?: Rimegepant as needed provides preventive benefit. A comment on: monthly migraine days, tablet utilization, and quality of life associated with rimegepant—post hoc results from an open label safety study (BHV3000–201)
por: Gantenbein, Andreas R., et al.
Publicado: (2023)

Human Milk and Lactation
por: Gianni, Maria Lorella, et al.
Publicado: (2020)

The Low-Dose (7.5 mg/day) Pioglitazone Therapy
por: Yanai, Hidekatsu, et al.
Publicado: (2017)

Pharmacokinetics, Milk Residues, and Toxicological Evaluation of a Single High Dose of Meloxicam Administered at 30 mg/kg per os to Lactating Dairy Cattle
por: Fritz, Scott A., et al.
Publicado: (2023)

A single-dose, randomized, open-labeled, parallel-group study comparing the pharmacokinetics, pharmacodynamics and safety of leuprolide acetate microspheres 3.75 mg and Enantone(®) 3.75 mg in healthy male subjects
por: Hu, Xingjiang, et al.
Publicado: (2022)

Comparative pharmacokinetics between two tablets of tramadol 37.5 mg/acetaminophen 325 mg and one tablet of tramadol 75 mg/acetaminophen 650 mg for extended-release fixed-dose combination
por: Kim, Hyun Chul, et al.
Publicado: (2022)

Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy
por: Mullin, Kathleen, et al.
Publicado: (2020)

Lactoferrin in Human Milk of Prolonged Lactation
por: Czosnykowska-Łukacka, Matylda, et al.
Publicado: (2019)

75 Efficacy of Slow Oral Immunotherapy for Cow's Milk Allergy
por: Ogura, Kiyotake, et al.
Publicado: (2012)

Effectiveness of posthemodialysis administration of pregabalin (75 mg) in treatment resistance uremia pruritus
por: Khan, Tahir Mehmood, et al.
Publicado: (2016)

Carcinogens in Rat Milk: Transfer of Ingested Diethylnitrosamine into Milk by Lactating Rats
por: Schoental, R., et al.
Publicado: (1974)

Randomized clinical trial of dexketoprofen/tramadol 25 mg/75 mg in moderate-to-severe pain after total hip arthroplasty
por: McQuay, H. J., et al.
Publicado: (2016)

Microbiota in Breast Milk of Chinese Lactating Mothers
por: Sakwinska, Olga, et al.
Publicado: (2016)

Lactation Stage-Dependency of the Sow Milk Microbiota
por: Chen, Wei, et al.
Publicado: (2018)

Breast Milk Macronutrient Components in Prolonged Lactation
por: Czosnykowska-Łukacka, Matylda, et al.
Publicado: (2018)

A Systematic Review of Flurbiprofen 8.75 mg Dose and Risk of Haemorrhagic Events
por: Dhanda, Sandeep, et al.
Publicado: (2021)

Characterization of erenumab and rimegepant on calcitonin gene-related peptide induced responses in Xenopus Laevis oocytes expressing the calcitonin gene-related peptide receptor and the amylin-1 receptor
por: Hage La Cour, Sanne, et al.
Publicado: (2022)

Metabolic Risk Profile among Overweight and Obese Lactating Women in Sweden
por: Winkvist, Anna, et al.
Publicado: (2013)

The Mean of Milk: A Review of Human Milk Oligosaccharide Concentrations throughout Lactation
por: Soyyılmaz, Buket, et al.
Publicado: (2021)

Effects of ecotrofin™ on milk yield, milk quality and serum biochemistry in lactating goats
por: Musco, Nadia, et al.
Publicado: (2021)

Dexketoprofen/tramadol 25 mg/75 mg: randomised double-blind trial in moderate-to-severe acute pain after abdominal hysterectomy
por: Moore, R. A., et al.
Publicado: (2016)

Comparison of two doses of hypobaric bupivacaine in unilateral spinal anesthesia for hip fracture surgery: 5 mg versus 7.5 mg
por: Kahloul, Mohamed, et al.
Publicado: (2017)

Energy and reactivity profile and proton affinity analysis of rimegepant with special reference to its potential activity against SARS-CoV-2 virus proteins using molecular dynamics
por: Pooventhiran, T., et al.
Publicado: (2021)

Correction to: Dexketoprofen/tramadol 25 mg/75 mg: randomised double-blind trial in moderate-to-severe acute pain after abdominal hysterectomy
por: Moore, R. A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bp5knkfac4rnina6n20grj4tfv